Disorders of the skin. Acne vulgaris
Tring, F.C.
Nursing Times 72(35): 1344-1346
1976
ISSN/ISBN: 0954-7762 PMID: 134355 Document Number: 109195
Document emailed within 1 workday
Related Documents
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740Jakobza, D.; Reichmann, G.; Langnick, W.; Langnick, A.; Schulze, P. 1981: Surface skin lipids in acne vulgaris Dermatologische Monatschrift 167(2): 104-107
Spann, C.T. 2011: Ten tips for treating acne vulgaris in Fitzpatrick skin types IV-Vi Journal of Drugs in Dermatology: Jdd 10(6): 654-657
Brown, E.J. 1977: A povidone-iodine skin cleanser foam in the management of acne vulgaris British Journal of Clinical Practice 31(12): 218-219
Alexis, A.F. 2014: Acne vulgaris in skin of color: understanding nuances and optimizing treatment outcomes Journal of Drugs in Dermatology: Jdd 13(6): S61-S65
Schrodt, B.J.; Kulp-Shorten, C.L.; Callen, J.P. 1999: Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris Southern Medical Journal 92(5): 502-504
Taylor, S.C.; Cook-Bolden, F.E.; McMichael, A.; Downie, J.B.; Rodriguez, D.A.; Alexis, A.F.; Callender, V.D.; Alvandi, N. 2018: Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype Journal of drugs in dermatology: JDD 17(2): 160-167
Amar, L.; Kircik, L.H. 2018: Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel Journal of Drugs in Dermatology: Jdd 17(10): 1107-1112
Mazurkiewicz, W.; Kostanecki, W.; Blaszczyk, M.; Dabrowska, H. 1974: Treatment of some diseases involving keratinization such as acne vulgaris and acne phlegmonosa with vitamin a acid Przeglad Dermatologiczny 61(1): 61-64
Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Jemec, G.B.E.; Linneberg, A.; Nielsen, N.Henrik.; Frølund, L.; Madsen, F.; Jørgensen, T. 2002: Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives Dermatology 204(3): 179-184
Schneider, W. 1973: Acne vulgaris Deutsche Medizinische Wochenschrift 98(32): 1511
Polano, M.K. 1974: Acne vulgaris Nederlands Tijdschrift Voor Geneeskunde 118(3): 81-84
Turner, T.W. 1976: Acne vulgaris Medical Journal of Australia 1(18): 672-673
Rabinowitz 1997: Acne Vulgaris Adolescent Medicine 8(1): 77-86
Shapiro, S.C. 1984: Acne vulgaris in adolescence Arizona Medicine 41(2): 98-100
Leyh, F. 1974: On the therapy of acne vulgaris Minerva Medica 65(23): 1257-1259
Skendzić, M.; Blagojević, D. 1981: Treatment of acne vulgaris Srpski Arhiv Za Celokupno Lekarstvo 109(8): 1049-1056
Quan, M.; Strick, R.A. 1988: Management of acne vulgaris American Family Physician 38(2): 207-218
Murphy, G. 1999: Management of acne vulgaris Irish Medical Journal 92(5): 360-361